Labots M - Search Results

1

Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

Geurts BS, Zeverijn LJ, van Berge Henegouwen JM, van der Wijngaart H, Hoes LR, de Wit GF, Spiekman IA, Battaglia TW, van Beek DM, Roepman P, Jansen AM, de Leng WW, Broeks A, Labots M, van Herpen CM, Gelderblom H, Verheul HM, Snaebjornsson P, Voest EE. Geurts BS, et al. Among authors: labots m. J Pathol. 2024 Jul;263(3):288-299. doi: 10.1002/path.6279. Epub 2024 May 15. J Pathol. 2024. PMID: 38747304

2

[Endocrine side effects of checkpoint inhibitors].

Chen WJY, Krul-Poel YHM, Roth C, Labots M, van den Eertwegh AJM, Dreijerink KMA. Chen WJY, et al. Among authors: labots m. Ned Tijdschr Geneeskd. 2019 Oct 31;163:D3957. Ned Tijdschr Geneeskd. 2019. PMID: 31714042 Dutch.

3

Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods.

Piersma SR, Labots M, Verheul HM, Jiménez CR. Piersma SR, et al. Among authors: labots m. Anal Bioanal Chem. 2010 Aug;397(8):3163-71. doi: 10.1007/s00216-010-3784-7. Epub 2010 Jun 8. Anal Bioanal Chem. 2010. PMID: 20526883 Free article. Review.

4

Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.

Gotink KJ, Broxterman HJ, Labots M, de Haas RR, Dekker H, Honeywell RJ, Rudek MA, Beerepoot LV, Musters RJ, Jansen G, Griffioen AW, Assaraf YG, Pili R, Peters GJ, Verheul HM. Gotink KJ, et al. Among authors: labots m. Clin Cancer Res. 2011 Dec 1;17(23):7337-46. doi: 10.1158/1078-0432.CCR-11-1667. Epub 2011 Oct 6. Clin Cancer Res. 2011. PMID: 21980135 Free PMC article.

5

High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.

Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA. Labots M, et al. Cell Oncol (Dordr). 2014 Feb;37(1):41-52. doi: 10.1007/s13402-013-0162-4. Epub 2013 Dec 31. Cell Oncol (Dordr). 2014. PMID: 24379144

6

Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.

Labots M, Schütte LM, van der Mijn JC, Pham TV, Jiménez CR, Verheul HM. Labots M, et al. Oncologist. 2014 Oct;19(10):1028-39. doi: 10.1634/theoncologist.2014-0101. Epub 2014 Sep 3. Oncologist. 2014. PMID: 25187478 Free PMC article. Review.

7

Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility study.

de Wit D, van Erp NP, den Hartigh J, Wolterbeek R, den Hollander-van Deursen M, Labots M, Guchelaar HJ, Verheul HM, Gelderblom H. de Wit D, et al. Among authors: labots m. Ther Drug Monit. 2015 Jun;37(3):331-8. doi: 10.1097/FTD.0000000000000141. Ther Drug Monit. 2015. PMID: 25271729 Clinical Trial.

8

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.

Labots M, Gotink KJ, Dekker H, Azijli K, van der Mijn JC, Huijts CM, Piersma SR, Jiménez CR, Verheul HM. Labots M, et al. Exp Mol Med. 2016 Dec 16;48(12):e279. doi: 10.1038/emm.2016.114. Exp Mol Med. 2016. PMID: 27980342 Free PMC article.

9

Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.

Labots M, van der Mijn JC, Beekhof R, Piersma SR, de Goeij-de Haas RR, Pham TV, Knol JC, Dekker H, van Grieken NCT, Verheul HMW, Jiménez CR. Labots M, et al. J Proteomics. 2017 Jun 6;162:99-107. doi: 10.1016/j.jprot.2017.04.014. Epub 2017 Apr 23. J Proteomics. 2017. PMID: 28442448

10

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

Labots M, Van der Mijn JC, Dekker H, Ruijter R, Pham TV, Van der Vliet HJ, Van der Hoeven JJM, Meijer GA, Verheul HMW. Labots M, et al. Oncologist. 2018 Oct;23(10):1135-e118. doi: 10.1634/theoncologist.2018-0263. Epub 2018 Jul 17. Oncologist. 2018. PMID: 30018133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters